Digital Adherence Program
Program overview
This sponsored program aims to provide education and support to patients prescribed Coveram for the treatment of high blood pressure and coronary heart disease.
Patients will receive a series of 12 messages over 9 months aimed at improving their quality use of medicines, medication adherence and treatment outcomes.
When?
This program was launched in February 2022.
For which patients?
Messages will be delivered via the app and SMS to patients currently prescribed Coveram.

© 2026 MedAdvisor International Pty Ltd